Revision as of 23:46, 17 October 2018

Design and Results

Results

Cell-free, synthetic biology systems open new horizons in engineering biomolecular systems which feature complex, cell-like behaviors in the absence of living entities. Having no superior genetic control, user-controllable mechanisms to regulate gene expression are necessary to successfully operate these systems. We have created a small collection of synthetic RNA thermometers that enable temperature-dependent translation of membrane proteins, work well in cells and display great potential to be transferred to any in vitro protein synthesis system.

Description

Fig. 5 expression at 24 ˚C. On the right you can see GFP expression without RNA thermometer.

Fig. 6 GFP expression at 30 ˚C. On the right you can see GFP expression without RNA thermometer.

Fig. 7 GFP expression in 37 ˚C. On the right you can see GFP expression without RNA thermometer.

Discussion

As described in other sections of the Design and results page , beta-barrel bearing proteins are assembled into the membrane by the BAM protein complex machinery. The key protein BamA is itself a membrane protein, whose folding and insertion into membrane where it helps assemble target proteins, last up to two hours. In order to prevent the aggregation of our fusion proteins after encapsulating their gene-bearing plasmids and purified BamA mRNA into liposomes, we needed to develop a modulatory regulatory tool to lock the translation of our membrane proteins to allow enough time for the encapsulated BamA to fold and insert into the liposome membrane.

Fig. 8 Associational scheme of thermoswitches’ action in the SynDrop system. Not locking the concomitant translation of our target protein and BamA results in target protein aggregation due to insufficient membrane insertion and assembling potential of BamA.

Fig. 9 Associational scheme of thermoswitches’ action in the SynDrop system. Locking up translation gives time for proper folding and insertion of BamA and prevents undesirable aggregation of target membrane proteins.

Additionally, while creating SynDrop, we have considered various options on how to make our complex cell-free system more user-controllable and predictable. Cell-free systems are becoming an attractive platform for in vitro compartmentalization and protein research, and although usually compositionally sensitive, they also offer a platform for building synthetic genetic regulatory tools or logic gates. Both the need to control the translation time of target genes and desire to provide more modularity for our synthetic system, led us to exploring RNA thermometers as a viable option to perform these tasks. They have minimal molecular burden and are easy to modulate. These properties encouraged us to developed a library of synthetic RNA thermometers suitable to translationally regulate the expression of our fusion constructs in bacteria with a further possibility to transfer them to IVTT systems. All of the RNA thermometers including those we found in literature and our de novo modelled ones were optimized for best performance at 37^oC, bearing in mind their future transition to IVTT system, whose optimum performance temperature is also 37^oC. Consequently, our experiments showed that our synthetic RNA thermometers, despite their simplistic structures compared to naturally occurring ones, efficiently triggered the expression of target constructs at 37^oC, and successfully locked it at lower temperatures having made them an ideal complement to our liposome IVTT system. All of our thermoswitches unlocked the expression to similarly high levels at 37^oC, but differed in terms of leakiness and success at inhibiting translation at lower temperatures.

Conclusions

We proved that herein described synthetic RNA thermometers enable high-yield expression of our constructs in an inducible temperature range. What is more important, this spectrum of temperature is compatible with currently used in vitro transcription and translation systems. Synthetic Thermoswitches allow the user-controllable and responsive protein translation for custom experiments. Finally, we introduced six de novo designed RNA thermoswitches which will have been used by future iGEM teams having to work both with cell-free and in vivo synthetic biology systems.

References

1. Neupert J, Karcher D, Bock R. Design of simple synthetic RNA thermometers for temperature-controlled gene expression in Escherichia coli. Nucleic Acids Res. Oxford University Press; (2008); 36:e124–e124.
2. Narberhaus F, Waldminghaus T, Chowdhury S. RNA thermometers. FEMS Microbiol. Rev. Wiley/Blackwell (10.1111); (2006); 30:3–16.
3. Storz G. An RNA thermometer. Genes Dev. Cold Spring Harbor Laboratory Press; (1999); 13:633–6.
4. Sen S, Apurva D, Satija R, Siegal D, Murray RM. Design of a Toolbox of RNA Thermometers. ACS Synth. Biol. (2017); 6:1461–70.

Mistic fusion protein

Liposomes Ribosome modifications BAM complex RNA Thermoswitches Mistic fusion protein Surface display system

Mistic Fusion Protein

Self-inserting Bacillus subtilis protein called Mistic (MstX) is originally involved in biofilm formation¹. It is thought that MstX might directly chaperon the membrane insertion of potassium ion channel YugO. Together these proteins create a positive autoregulatory feedback loop that assists biofilm assembly in a population of cells and is mediated by a pathway involving potassium ion efflux².

MstX comprises 110 residues that are arranged into a four-helix bundle exposing numerous polar and charged amino acids (Fig. 1). This α-helical protein is characterized by an uncommonly hydrophilic surface. Until this day there is a great debate on how MstX is able to autonomously associate with a lipid bilayer despite its hydrophilic surface ². It is known that three of the four MstX helices are much shorter than transmembrane helices of canonical integral MPs. In general, the four helices of this protein show no apparent differences in hydrophobicity or charge distribution among each other.

Fig. 1 NMR structure of Mistic (MstX). Protein is comprised of four ɑ-helices with a polar lipid-facing surface. Topology measurements have shown that both C-terminus and N-terminus of MstX are exposed at the same side. Adapted by Yarnell, 2005

MstX was identified back in 2005 by Rooslid and colleagues. Interestingly, until this day little is known about how MstX promotes integral protein targeting to the membrane³. Recently it has found a novel application as a fusion tag supporting the recombinant production and bilayer insertion of other membrane proteins (MPs)¹. MstX, when fused to the N-terminus of integral MPs, enables the cargo proteins to fold into their native conformations in the membrane, thus yielding high-level expression. It is known that MstX autonomously targets proteins to the membrane bypassing the canonical secretory apparatus, like Sec translocon. In addition to this, it was indirectly presumed that MstX lacks any recognizable signal sequence ².

According to this, we have decided to implement the advantages of MstX into our project. In order to boost protein expression yield MstX was fused with target integral membrane protein Outer membrane protein A (OmpA). Prior using these recombinant proteins in cell-free system, it has to be ensured that proteins are expressed in bacteria. To do so, E. coli BL21 stain cells were transformed and induced for 2 and 4 hours with isopropyl β-D-1-thiogalactopyranoside (IPTG). Results were analyzed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). This experiment was conducted in order to detect if there are any differences in protein production yield comparing native and MstX-fused proteins.

First of all, it was concluded that MstX-OmpA-X and OmpA-X (X - additional part of the construct) are expressed in cells (Fig. 2).

Fig. 2 OmpA-X and MstX-OmpA-X (X - additional part of the construct; shown with arrows) expression in E. coli; SDS-PAGE after induction with IPTG for 2 hours and 4 hours; K - control, M - protein ladder

Also, we checked if we could fuse MstX with other integral membrane proteins. In this case, IgA protein (Fig. 3).

Fig. 3 IgA, IgA-MstX, and X-IgA-MstX (X - additional part of the construct; shown with arrows) expression in E. coli; SDS-PAGE; U4-2 - samples affected with 8M urea, S2-4 - samples affected with protein denaturation dye, K - control, M - protein ladder

Analyzing electrophoresis gel, differences of native IgA protein and recombinant IgA fused with MstX can be observed. It is extremely important that MstX in this case ensures higher-level yield of integral membrane proteins in E. coli as well.

According to these results, we validated that chosen integral membrane proteins are expressed in cells. In addition to this, their expression in cell-free system could be also expected. Moreover, MstX increases these MPs yield by functioning as a chaperone and enabling our target proteins to fold into their native conformations in the membrane even more efficiently.

Using MstX in cell-free systems is extremely advantageous as it allows effortless protein research without any need for additional protein purification step. Also, this fusion tag is universal as MstX it is compatible with different kinds of membrane proteins. In addition to this, the final task was to refine our cell-free system with MstX in order to make system more efficient and even more suitable for protein research.

To demonstrate that MstX is beneficial to cell-free system not only for membrane protein expression, it was fused with single-chain variable fragment (scFv; Fig. 3). It was decided to do so as scFvs are usually prone to form aggregates and lose their function in vitro. We thought that MstX could stabilize scFvs and prevent aggregation. As a result, we observed that MstX fusion could enhance scFv solubility allowing it to use in cell-free systems.

Fig. 4 Single-chain variable fragment (scFv) expression in IVTT system; SDS-PAGE. M - protein ladder, + - positive control DHFR, 1 - scFv, 2 - MstX-scFv, - negative control (without template DNA)

Analyzing the reaction samples, sediments in scFv were observed, which meant that scFv aggregated. However, in MstX-scFv sample there were no sediments. By analysing electrophoresis results (Fig. 4) it can be seen that MstX prevented formation of the aggregates which resulted in higher scFv expression yield.

References

1. Broecker, J., Fiedler, S., Gimpl, K. & Keller, S. Polar Interactions Trump Hydrophobicity in Stabilizing the Self-Inserting Membrane Protein Mistic. Journal of the American Chemical Society 136, 13761-13768 (2014).
2. Textor., M. Reconstitution and Membrane Topology of Mistic from Bacillus subtilis (Doctoral dissertation). University of Kaiserslautern. Retrieved from https://kluedo.ub.uni-kl.de
3. Lundberg, M. E. Biochemical and functional characterization of MISTIC. (Doctoral dissertation). UC San Diego. Retrieved from https://escholarship.org/uc/item/5b594287 (2013).

Surface display system

Liposomes Ribosome modifications BAM complex RNA Thermoswitches Mistic fusion protein Surface display system

ScFv Antibody

Background

scFv consists of a minimal functional antigen-binding domain of an antibody (~30 kDa) (Fig. 1) , in which the heavy variable chain (VH) and light variable chain (VL) are connected by Ser and Gly rich flexible linker. [1] In most cases scFv is expressed in bacteria, where it is produced in cytoplasm, a reducing environment, in which disulfide bonds are not able to form and protein is quickly degraded or aggregated. Although poor solubility and affinity limit scFvs’ applications, their stability can be improved by merging with other proteins. [2] When expressed in cell free system, scFv should form disulfide bonds with the help of additional molecules. Merging to a membrane protein would provide additional stability and would display scFv on liposome membrane, where its activity could be detected. These improved qualities make ScFv recombinant proteins a perfect tool to evaluate, if SynDrop system acts in an anticipated manner. Of all possible scFvs we decided to use scFv-anti vaginolysin, which binds and neutralizes toxin vaginolysin (VLY). Its main advantage is rapid (< 1 h) and cheap detection of activity by inhibition of erythrocyte lysis (Fig. 2). Looking into future applications, scFvs are also attractive targets of molecular evolution, because one round of evolution would last less than one day thus generating a and wide range of different scFv mutants. Those displaying the highest affinity for antigens could be selected and used as drugs or drug carriers.

Fig. 1 Simplified structure of scFv Antibody

Fig. 2 Scheme of scFv_antiVLY and VLY interaction. Left- scFv_antiVLY binds to VLY, erythrocytes stay intact, Right- scFv_antiVLY does not bind and VLY lyse erythrocytes.

Results

scFv constructs were created BBa_K2622004. and checked by colony PCR and DNA sequencing. scFv synthesis was performed in a cell free system. Validation of protein expression was done by running a sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE), see (Fig. 3)

Fig. 3 SDS-PAGE of scFv. GFP is used as positive control, C- chaperone DnaK.

Red arrows in the photo indicate scFv anti-vaginolysin (~27 kDa). As successful synthesis was confirmed, the next step was to check if protein folded correctly and was able to bind its antigen - vaginolysin. We examined this by erythrocyte-lysis test, which was performed by comparing erythrocytes incubated with VLY (erythrocytes burst open) and erythrocytes incubated with VLY that was previously incubated with scFv anti-vaginolysin (less or no erythrocyte lysis). Results revealed that scFv binded to vaginolysin and inhibited cell lysis. Graph in (Fig. 4) demonstrates that scFv indeed attenuated the lysis of erythrocytes. These result prove scFv activity in IVTT system.

Fig. 4 Percentage of erythrocyte lysis at different +/-scFv dilutions.

We then went one step further and constructed MstX-scFv_antiVLY BBa_2622038, fusion protein, aiming to increase the stability of scFv having in mind future applications and experiments of exposing it on liposome surface. Fusion protein was expressed in E.coli cells; yellow to red arrows in (Fig. 5A) indicate MstX-scFv expression after induction with IPTG.

Finally, we expressed the protein in a cell free system (Fig. 5B) along with scFv in order to compare how well scFv accomplishes its function alone or binded to other protein. In this case MstX-scFv_antiVLY fusion did not show superior activity than scFv_antiVLY alone (Fig. 6). These results also reveal that scFv_antiVLY is very sensitive and loses its activity with time. Ist and IInd attempts were separated by 1-2 hours. This amount of time is enough to measure decreasing activity. This must be taken into account when performing future experiments.

Fig. 5 A- MstX-scFv_antiVLY expression in Escherichia coli. B- scFv_antiVLY and MstX-scFv_antiVLY expression in cell-free system.

Fig. 6 Fig 6. Percentage of erythrocyte lysis at different scFv/MstX-scFv dilutions.

Conclusions

We successfully expressed scFv_antiVLY antibody and MstX-scFv_antiVLY construct in E.coli cells as well as in a cell free system. We demonstrated that our scFv anti-vaginolysin can bind to its target antigen vaginolysin and inhibit erythrocyte-lysis reaction. Based in scFv general properties in IVTT activity, we conclude that scFvs are an elegant addition to SynDrop liposome display system.

Discussion

Small size of scFv makes it a widely researched antibody. It’s ability to penetrate deeply into tissues and trait to elicit low to none organism’s immune response, makes scFv the one of the best candidates for medical, diagnostic, and research applications [3]. Efficient and fast method for scFv generation is in demand. SynDrop liposome display system offers an ability to produce scFv in IVTT system and display them on membranes to facilitate rapid antigen binding. scFv on the other hand can also help us prove that our system work either cost efficiently or with extreme precision. scFv surface display is compatible with using fluorescence assisted cell sorting (FACS) to detect well functioning liposomes. [4] This would reduce amount of time needed for mutant sorting compared with enzyme-linked immunosorbent assay. Second, scFv display is compatible with the experiments described in this section. We have performed erythrocyte-lysis tests to prove the functional activity of scFv anti-vaginolysin that was synthesized in the IVTT system. Not all experiments with VLY indicated positive antibody activity. We hypothesized that proteins could have aggregated very quickly after IVTT expression and the amount of active antibody left in the solution was not enough to inhibit VLY in quantities, what would have been detectable. This hypothesis was further supported by several experiments, which revealed decreasing scFv antibody’s functional activity with time. Moreover, not every experiment was done just after IVTT reaction completed and spend few hours in +4 ˚C. Another option to test scFv, single or displayed on liposomes to gain most reliable results, is an ELISA test. It requires specific antibodies and tags (His-6x or Strep-tag) on scFv or MstX-scFv.

Refferences

Monnier, P., Vigouroux, R. & Tassew, N. In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments. Antibodies 2, 193-208 (2013).
Wang, R. et al. Engineering production of functional scFv antibody in E. coli by co-expressing the molecule chaperone Skp. Frontiers in Cellular and Infection Microbiology 3, (2013).
Ahmad, Z. et al. scFv Antibody: Principles and Clinical Application. Clinical and Developmental Immunology 2012, 1-15 (2012).
Vorauer-Uhl, K., Wagner, A., Borth, N. & Katinger, H. Determination of liposome size distribution by flow cytometry. Cytometry 39, 166 (2000).

@@ Line 222: / Line 222: @@
                    With custom IDT primers with overhangs bearing thermoswitch sequences we performed a PCR  from a GFP gene containing plasmid and inserted RNA thermometers GJ<sub>x</sub> (link: <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2622010">BBa_K2622010</a>, <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2622011">BBa_K2622011</a>, <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2622012">BBa_K2622012</a>, <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2622013">BBa_K2622013</a>, <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2622014">BBa_K2622014</a>) upstream the GFP gene. Another set of primers was used to produce RNA thermometers Sw<sub>x</sub> (link: <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2622016">BBa_K2622016</a>, <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2622017">BBa_K2622017</a>, <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2622018">BBa_K2622018</a>, <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2622019">BBa_K2622019</a>, <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2622020">BBa_K2622020</a>, <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2622021">BBa_K2622021</a>). PCR was successful and all products were the same size as expected for Sw<sub>x</sub> constructs ~76 bp (Fig. 2). DNA gel electrophoresis was not performed for GJx constructs, because whole plasmid was multiplied and only 40-60 bp were inserted.
                 </p>
-                <p>
+                <p> <div class="image-container"></div>
                    <img src="https://static.igem.org/mediawiki/2018/c/ca/T--Vilnius-Lithuania--THERMO_fig_2.png"/>
                    <strong>Fig. 2</strong> Electrophoresis gel of PCR products: 6 - Sw2, 7 - Sw3, 8 - Sw6, 9 - Sw7, 10 - Sw9, 11 - Sw11.
                 </p>
+            </div>
                 <p>
                    pRSET plasmid and Sw<sub>x</sub> PCR products were digested with restriction enzymes and ligated, while GJ<sub>x</sub> PCR products were phosphorylated and ligated to produce plasmids from linear products. DH5α competent cells were transformed and plated on lysogeny broth (LB) media with ampicillin (Amp) and grown for 16 hours. Positive colonies were selected by colony PCR or restriction analysis (Fig. 3 and Fig. 4) and grown in 5 mL LB media. Plasmids were purified and BL21 competent cells were transformed. Three tubes of every construct plus plasmid with GFP without RNA thermometer were grown till OD<sub>600</sub> reached 0.4. Control samples were taken and protein expression was induced with Isopropyl β-D-1-thiogalactopyranoside (IPTG). One tube of every construct was grown in 24 ˚C, 30 ˚C, and 37 ˚C. Samples were taken after 1 and 2 hours. SDS-PAGE was run (for elaborate protocol see Notebook/<a href="https://2018.igem.org/Team:Vilnius-Lithuania/Protocols">Protocols</a>). Fig. 5, Fig 6 and Fig. 7 depicts GFP expression at different temperatures. Although our RNA thermometers were designed to melt at 37 ˚C, some displayed leakiness to different extent. GJ3 (link:<a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2622011">BBa_K2622011</a>) RNA thermometer was the leakeast and allowed for GFP translation at lower temperatures. On the other hand, when grown at 37 ˚C, it unlocked the translation of GFP to highest yields. GJ2 (link:<a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2622010">BBa_K2622010</a>) was less leaky, but inhibited protein translation more strictly when grown at 37 ˚C. GJ6 (link: <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2622012">BBa_K2622012</a>), GJ9 (link:<a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2622013">BBa_K2622013</a>), and GJ10 (link: <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2622014">BBa_K2622014</a>) suppressed GFP production at 24 ˚C and 30 ˚C at similar level. They also inhibited translation to some extent at higher temperatures, meaning their melting temperature was not reached. Altogether these results prove, that our synthetic thermoswitches are temperature-responsive and act in physiological temperature range needed for IVTT reaction and also for BamA folding and membrane insertion.
                 </p>
-                <p>
+                <p> <div class="image-container"></div>
                    <img src="https://static.igem.org/mediawiki/2018/d/d8/T--Vilnius-Lithuania--THERMO_fig_3.png"/>
                    <strong>Fig. 3</strong> Restriction analysis of GJ<sub>x</sub> constructs
                 </p>
-                <p>
+            </div>
+                <p> <div class="image-container"></div>
                    <img src="https://static.igem.org/mediawiki/2018/a/a4/T--Vilnius-Lithuania--THERMO_fig_4.png"/>
                    <strong>Fig. 4</strong> Colony PCR of RNA thermometers in pSB1C3 plasmid.
                 </p>
-                <p>
+            </div>
+                <p> <div class="image-container"></div>
                    <img src="https://static.igem.org/mediawiki/2018/4/46/T--Vilnius-Lithuania--THERMO_fig_5.png"/>
                    <strong>Fig. 5</strong> expression at 24 ˚C. On the right you can see GFP expression without RNA thermometer.
                 </p>
-                <p>
+            </div>
+                <p> <div class="image-container"></div>
                    <img src="https://static.igem.org/mediawiki/2018/d/dd/T--Vilnius-Lithuania--THERMO_fig_6.png"/>
                    <strong>Fig. 6</strong> GFP expression at 30 ˚C. On the right you can see GFP expression without RNA thermometer.
                 </p>
-                <p>
+            </div>
+                <p> <div class="image-container"></div>
                    <img src="https://static.igem.org/mediawiki/2018/7/78/T--Vilnius-Lithuania--THERMO_fig_7.png"/>
                    <strong>Fig. 7</strong> GFP expression in 37 ˚C. On the right you can see GFP expression without RNA thermometer.
                 </p>
+            </div>
                 <p></p>
                 <h1>Discussion</h1>

Difference between revisions of "Team:Vilnius-Lithuania/Design"

Revision as of 23:46, 17 October 2018

Design and Results

Results

Liposomes

Ribosome modifications

Background

Nickel-chelating lipids and polyhistidine tags as potential solution

Results

Designing the modifications

Modification procedure

Conclusion and Discussion

References

BAM complex

RNA Thermoswitches

Background

Results

Discussion

Conclusions

References

Mistic fusion protein

Mistic Fusion Protein

References

Surface display system

ScFv Antibody

Background

Results

Conclusions

Discussion

Refferences